SECONDARY CEREBELLAR DEGENERATION

This adverse event was reported 62 times

These drugs are most commonly taken by patients reporting SECONDARY CEREBELLAR DEGENERATION:

# Drug Count
0 CARBOPLATIN 24
1 PACLITAXEL 23
2 PACLITAXEL (AIBUMIN-BOUND) 23
3 PERTUZUMAB 9
4 TRASTUZUMAB 9
5 DOXORUBICIN 8
6 BEVACIZUMAB 7
7 PEMBROLIZUMAB 5
8 NIVOLUMAB 4
9 DURVALUMAB 3
See all common drugs associated with SECONDARY CEREBELLAR DEGENERATION

SECONDARY CEREBELLAR DEGENERATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-MALY 1 0.0050
1 TOPOTECAN HYDROCHLORIDE 2 0.0008
2 MIRVETUXIMAB SORAVTANSINE 1 0.0006
3 DOSTARLIMAB 1 0.0004
4 PERTUZUMAB 9 0.0003
5 PACLITAXEL 23 0.0002
6 BEVACIZUMAB-AWWB 1 0.0002
7 CARBOPLATIN 24 0.0002
8 VINORELBINE 1 0.0001
9 DURVALUMAB 3 0.0001
See all drugs enriched for association with SECONDARY CEREBELLAR DEGENERATION